top of page

SOMNIUM  EQUESTRIAN

Favourite Accomplished Equestrian Athletes

Public·6 members
Elias Perez
Elias Perez

Download 767 Delta Rar


NKG2D is an important immunoreceptor expressed on the surface of NK cellsand some T cells. NKG2D recognizes a set of ligands typically expressed oninfected or transformed cells, but recent studies have also documented NKG2Dligands on subsets of host non-tumor cells in tumor-bearing animals andhumans. Here we show that in transplanted tumors and genetically engineeredmouse cancer models, tumor-associated macrophages are induced to express theNKG2D ligand RAE-1[delta]. We find that a soluble factor produced by tumorcells is responsible for macrophage RAE-1[delta] induction, and we identifytumor-derived colony-stimulating factor-1 (CSF-1) as necessary and sufficientfor macrophage RAE-1[delta] induction in vitro and in vivo. Furthermore, weshow that induction of RAE-1[delta] on macrophages by CSF-1 requires PI3Kp110[alpha] kinase signaling. Thus, production of CSF-1 by tumor cellsleading to activation of PI3K p110[alpha] represents a novel cellular andmolecular pathway mediating NKG2D ligand expression on tumor-associatedmacrophages.




Download 767 Delta rar


Download: https://www.google.com/url?q=https%3A%2F%2Fvittuv.com%2F2uiyRX&sa=D&sntz=1&usg=AOvVaw0ZJ37a1AT6ZDJ-L7ybCHho



NKG2D is a lectin-like cell surface immunoreceptor expressed on all NK cellsand some T cell subsets (Raulet, 2003 (36)). NKG2D recognizes a diverse setof MHC-like proteins. In mice, these include the RAE-1 family (includingisoforms [alpha], [beta], [gamma], [delta], and [epsilon]), the H60 family(a, b, c), and MULT1. Human NKG2D ligands include the ULBP family (withisoforms 1--6) and the MICA and MICB proteins (Raulet et al., 2013 (35)).


Here we show that the NKG2D ligand RAE-1[delta] is induced ontumor-associated macrophages but not other cells that infiltrate severalmodels of transplanted and autochthonous cancer. Unexpectedly, we find thatthe cytokine colony-stimulating factor-1 (CSF-1) is released by tumor cellsand is necessary and sufficient to induce RAE-1[delta] at the mRNA and cellsurface levels on macrophages in vitro and on tumor-associated macrophages invivo. Furthermore, we show that the p110[alpha] catalytic subunit of PI3K isrequired for CSF-1-mediated macrophage RAE-1[delta] induction. Thus, tumorcell secretion of CSF-1 is sensed by macrophages through CSF-1R and PI3Kp110[alpha], leading to induction of the NKG2D ligand RAE-1[delta].


A limited number of studies have described NKG2D ligand expression on subsetsof tumor-associated hematopoietic cells (Crane et al., 2014 (3); Deng et al.,2015 (4); Nausch et al., 2008 (30)). To further investigate this phenomenon,we used flow cytometry to analyze NKG2D ligands on hematopoietic cellsinfiltrating several transplant tumor models. First, WT C57BL/6 mice wereinjected subcutaneously with a high dose (1 x 106) of B16-BL6 melanoma cells, hereafter referred to as B16. Once establishedat approximately 1 cm in diameter (10--17 days post-injection), tumors weredissociated and stained with lineage markers and monoclonal antibodies forNKG2D ligands, including RAE-1[delta], RAE-1[epsilon], MULT1, or a polyclonalantibody that recognizes multiple H60 isoforms. As RAE-1 molecules are quitesimilar, we validated the specificity of the antibodies by staining B16 cellstransduced with RAE-1[delta] or RAE-1[epsilon] with the antibodies targetingthese ligands (Figure 1--figure supplement 2A), and we previously confirmedisoform-specific blocking by these antibodies (Thompson et al., 2017 (39)).


Tumor-associated macrophages (hereafter called TAMs) are an important subsetof myeloid cells identified as CD45-pos; CD11b-hi; Ly6G-neg; F4/80-hi (Figure1--figure supplement 1A). Interestingly, TAMs in B16 tumors expressedRAE-1[delta] but not other NKG2D ligands (Figure 1A). In addition to strongexpression on TAMs, RAE-1[delta] was weakly expressed on monocytes in B16tumors (identified as CD45-pos; CD11b-hi; Ly6G-neg; F4/80-low; Ly6C-hi --gating strategy in Figure 1--figure supplement 3A) -- but negligible on otherhematopoietic cells (Figure 1B). Importantly, RAE-1[delta] staining on TAMswas completely absent in RAE-1-KO mice, which contain frameshift mutations inthe genes encoding RAE-1[delta] and RAE-1[epsilon], confirming thespecificity of the RAE-1[delta] staining (Figure 1--figure supplement 1B). Incontrast to robust TAM expression of RAE-1[delta], splenic macrophages,peritoneal macrophages, and blood monocytes in mice bearing B16 tumorsexpressed little to no RAE-1[delta] (Figure 1--figure supplements 1C and3B,C). These data indicate that macrophages within the B16 tumormicroenvironment are induced to express the NKG2D ligand RAE-1[delta].Expression of RAE-1[delta] in TAMs within B16 tumors was similar at variousstages of tumor growth (Figure 1--figure supplement 2B). Gating strategiesfor blood monocytes and peritoneal macrophages are shown in Figure 1--figuresupplement 3.


Figure 1. RAE-1[delta] is induced on tumor-associated macrophagesin subcutaneously transferred and spontaneous tumors. (A) Established B16 S.C. tumors were dissociated and analyzed for NKG2D ligandexpression on tumor-associated macrophages. (B) RAE-1[delta] expression (left) and MFI quantification (right) on theindicated cell types in B16 tumors. (C) RAE-1[delta] expression on TAMs in spontaneous KP sarcoma, but not inspontaneous TRAMP prostate adenocarcinoma or transferred RMA-S lymphoma. Dataare representative of >3 independent experiments.


Figure 1--figure supplement 1. Gating strategy and RAE1[delta]expression on tumor-associated macrophages and monocytes in mice with B16tumors. (A) Gating strategy to identify tumor-associated macrophages in B16 tumors. (B) Expression of RAE-1[delta] on TAMs in B16 S.C. tumors in WT and RAE-1-KOmice. (C) RAE-1[delta] expression on TAMs, splenic macrophages, blood monocytes, orperitoneal macrophages in WT mice with established B16 S.C. tumors. Data arerepresentative of >3 independent experiments.


Figure 1--figure supplement 2. RAE-1 antibody validation andRAE-1[delta] staining on TAMs in different tumors. (A) B16 cells transduced to stably express RAE-1[delta] or RAE-1[epsilon] werestained with biotinylated antibodies against RAE-1[delta] or RAE-1[epsilon],followed by fluorophore-conjugated streptavidin. (B) Expression of RAE-1[delta] on TAMs in B16 S.C. tumors in WT mice at theindicated time after injection of 1 x 106 tumor cells. (C) Expression of RAE-1[delta] on TAMs in S.C. B16 and RMA-S tumors andautochthonous KP and TRAMP tumors. Data are compiled from several independentexperiments.


In contrast to the findings with B16 tumors, RAE-1[delta] staining wasnegligible or very low on TAMs in similarly sized S.C. tumors generated byinjection of the RMA-S T cell lymphoma cell line (5 x 106 cells injected) (Figure 1C). We next sought to analyze NKG2D ligands ontumor-associated cells in spontaneous tumor models. In the KP sarcoma modeldriven by lentiviral-Cre activation of oncogenic Kras and deletion of Trp53 (DuPage et al., 2009 (7)), TAMs in primary tumors expressed robustRAE-1[delta] (Figure 1C). In contrast, TAMs within primary TRAMP prostatetumors -- a spontaneous adenocarcinoma model driven by expression of SV40 Tantigens (Greenberg et al., 1995 (14)) -- mostly lacked RAE-1[delta] (Figure1C). Together, these data indicate that TAMs, but not other hematopoieticcells, are induced to express RAE-1[delta] in some transplant and spontaneoustumors (B16 tumors and primary KP sarcomas), but not in others (RMA-S tumorsand primary TRAMP adenocarcinomas) (see Figure 1--figure supplement 2C forcomparisons). Thus, tumor microenvironments are differentially capable ofinducing NKG2D ligand expression by macrophages.


To interrogate the mechanism of RAE-1[delta] induction on TAMs, we began bytesting the hypothesis that a soluble factor released from tumor cellsinduces macrophage RAE-1[delta]. Resident macrophages were obtained fromnaïve WT mice by peritoneal lavage and cultured ex vivo with concentratedcell culture medium from B16 cells (diluted 1:1 with fresh medium) orsimilarly diluted concentrated fresh medium as a control. Macrophagescultured in the control medium showed little to no RAE-1[delta] expression,but culture with B16-conditioned medium led to a robust induction of cellsurface RAE-1[delta] (Figure 2A). RAE-1[delta] was similarly induced byculture medium from a KP sarcoma cell line (Figure 2B). These resultsindicated that a soluble factor(s) produced by B16 tumor cells and KP sarcomacells is sufficient to induce RAE-1[delta] on macrophages ex vivo.


Figure 2. B16 and KP cell line conditioned medium and CSF-1induces RAE-1[delta] on macrophages. (A) Peritoneal wash cells were cultured with a 1:1 mixture of fresh medium plus20X concentrated fresh medium or 20X concentrated B16 cell culturesupernatants, and macrophage RAE-1[delta] was analyzed by flow cytometry 48hr later. (B) Peritoneal wash cells were stimulated 48 hr ex vivo with a 1:1 mixture offresh medium supplemented with fresh medium or conditioned medium fromcultures of a KP sarcoma cell line generated from a primary KP sarcoma, andmacrophage RAE-1[delta] was analyzed 48 hr later by flow cytometry. (C) Peritoneal wash cells were cultured with or without 10 ng/ml CSF-1, withthe addition of control Ig or CSF-1R antibody (1 [mu]g/ml), and macrophageRAE-1[delta] was analyzed 48 hr later by flow cytometry. (D) Peritoneal macrophage Raet1d mRNA 48 hr after stimulation with or without the addition of CSF-1 (10ng/ml). (E) Peritoneal macrophage expression of the indicated NKG2D ligands 48 hr afterstimulation with CSF-1 or control medium. Data are representative of >3independent experiments.


Figure 2--figure supplement 1. Peritoneal macrophage CSFR1expression and dose-dependent RAE-1[delta] induction by CSF-1, and bonemarrow macrophage stimulation with CSF-1 or GM-CSF. (A) CSF-R1 expression on peritoneal macrophages ex vivo. (B) RAE-1[delta] expression on peritoneal macrophages cultured 48 hr with theindicated concentration of CSF-1. (C) RAE-1[delta] expression on bone-marrow-derived-macrophages generated using10 ng/ml CSF-1 or GMCSF. Data are representative of 2--3 independentexperiments. 041b061a72


About

Here's a group where everyone can discuss their favourite eq...
bottom of page